P1 latency as a biomarker for central auditory development in children with hearing impairment

Anu Sharma, Kathryn Martin, Peter Roland, Paul Bauer, Melissa H. Sweeney, Phillip Gilley, Michael Dorman

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

We used the latency of the P1 cortical auditory-evoked potential (CAEP) as a biomarker for the development of central auditory pathways in three children who received intervention through hearing aids and/or cochlear implants. Our goal was to examine the clinical feasibility of using the latency of the P1 CAEP as an objective tool to evaluate whether acoustic amplification for hearing-impaired children has provided sufficient stimulation for normal development of central auditory pathways. If clinicians have such a marker, then they can more confidently make a decision about whether to provide a child with a cochlear implant following an appropriate hearing-aid trial. Using the same marker, clinicians will also be able to monitor the maturation of central auditory pathways once electrical stimulation is initiated.

Original languageEnglish (US)
Pages (from-to)564-573
Number of pages10
JournalJournal of the American Academy of Audiology
Volume16
Issue number8
DOIs
StatePublished - 2005

Fingerprint

Auditory Pathways
Child Development
Hearing Loss
Auditory Evoked Potentials
Hearing Aids
Cochlear Implants
Biomarkers
Acoustics
Electric Stimulation
Hearing

Keywords

  • Amplification
  • Biomarker
  • Cochlear implant
  • Cortical auditory evoked potential
  • Hearing aid
  • Hearing impairment
  • Objective measure
  • P1
  • Plasticity

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Sharma, A., Martin, K., Roland, P., Bauer, P., Sweeney, M. H., Gilley, P., & Dorman, M. (2005). P1 latency as a biomarker for central auditory development in children with hearing impairment. Journal of the American Academy of Audiology, 16(8), 564-573. https://doi.org/10.3766/jaaa.16.8.5

P1 latency as a biomarker for central auditory development in children with hearing impairment. / Sharma, Anu; Martin, Kathryn; Roland, Peter; Bauer, Paul; Sweeney, Melissa H.; Gilley, Phillip; Dorman, Michael.

In: Journal of the American Academy of Audiology, Vol. 16, No. 8, 2005, p. 564-573.

Research output: Contribution to journalArticle

Sharma, A, Martin, K, Roland, P, Bauer, P, Sweeney, MH, Gilley, P & Dorman, M 2005, 'P1 latency as a biomarker for central auditory development in children with hearing impairment', Journal of the American Academy of Audiology, vol. 16, no. 8, pp. 564-573. https://doi.org/10.3766/jaaa.16.8.5
Sharma, Anu ; Martin, Kathryn ; Roland, Peter ; Bauer, Paul ; Sweeney, Melissa H. ; Gilley, Phillip ; Dorman, Michael. / P1 latency as a biomarker for central auditory development in children with hearing impairment. In: Journal of the American Academy of Audiology. 2005 ; Vol. 16, No. 8. pp. 564-573.
@article{6a6145e4a328469e9475e18251747517,
title = "P1 latency as a biomarker for central auditory development in children with hearing impairment",
abstract = "We used the latency of the P1 cortical auditory-evoked potential (CAEP) as a biomarker for the development of central auditory pathways in three children who received intervention through hearing aids and/or cochlear implants. Our goal was to examine the clinical feasibility of using the latency of the P1 CAEP as an objective tool to evaluate whether acoustic amplification for hearing-impaired children has provided sufficient stimulation for normal development of central auditory pathways. If clinicians have such a marker, then they can more confidently make a decision about whether to provide a child with a cochlear implant following an appropriate hearing-aid trial. Using the same marker, clinicians will also be able to monitor the maturation of central auditory pathways once electrical stimulation is initiated.",
keywords = "Amplification, Biomarker, Cochlear implant, Cortical auditory evoked potential, Hearing aid, Hearing impairment, Objective measure, P1, Plasticity",
author = "Anu Sharma and Kathryn Martin and Peter Roland and Paul Bauer and Sweeney, {Melissa H.} and Phillip Gilley and Michael Dorman",
year = "2005",
doi = "10.3766/jaaa.16.8.5",
language = "English (US)",
volume = "16",
pages = "564--573",
journal = "Journal of the American Academy of Audiology",
issn = "1050-0545",
publisher = "American Academy of Audiology",
number = "8",

}

TY - JOUR

T1 - P1 latency as a biomarker for central auditory development in children with hearing impairment

AU - Sharma, Anu

AU - Martin, Kathryn

AU - Roland, Peter

AU - Bauer, Paul

AU - Sweeney, Melissa H.

AU - Gilley, Phillip

AU - Dorman, Michael

PY - 2005

Y1 - 2005

N2 - We used the latency of the P1 cortical auditory-evoked potential (CAEP) as a biomarker for the development of central auditory pathways in three children who received intervention through hearing aids and/or cochlear implants. Our goal was to examine the clinical feasibility of using the latency of the P1 CAEP as an objective tool to evaluate whether acoustic amplification for hearing-impaired children has provided sufficient stimulation for normal development of central auditory pathways. If clinicians have such a marker, then they can more confidently make a decision about whether to provide a child with a cochlear implant following an appropriate hearing-aid trial. Using the same marker, clinicians will also be able to monitor the maturation of central auditory pathways once electrical stimulation is initiated.

AB - We used the latency of the P1 cortical auditory-evoked potential (CAEP) as a biomarker for the development of central auditory pathways in three children who received intervention through hearing aids and/or cochlear implants. Our goal was to examine the clinical feasibility of using the latency of the P1 CAEP as an objective tool to evaluate whether acoustic amplification for hearing-impaired children has provided sufficient stimulation for normal development of central auditory pathways. If clinicians have such a marker, then they can more confidently make a decision about whether to provide a child with a cochlear implant following an appropriate hearing-aid trial. Using the same marker, clinicians will also be able to monitor the maturation of central auditory pathways once electrical stimulation is initiated.

KW - Amplification

KW - Biomarker

KW - Cochlear implant

KW - Cortical auditory evoked potential

KW - Hearing aid

KW - Hearing impairment

KW - Objective measure

KW - P1

KW - Plasticity

UR - http://www.scopus.com/inward/record.url?scp=33644797776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644797776&partnerID=8YFLogxK

U2 - 10.3766/jaaa.16.8.5

DO - 10.3766/jaaa.16.8.5

M3 - Article

VL - 16

SP - 564

EP - 573

JO - Journal of the American Academy of Audiology

JF - Journal of the American Academy of Audiology

SN - 1050-0545

IS - 8

ER -